TECH OFFERS

The smart wall switch's core technology is centered around the conversion of initial voice-based signals into electrical signals. Through an innovative design, it efficiently generates DC power utilizing solely an AI voice recognition sensor and an existing AC power line. Remarkably, this cutting-edge switch is entirely independent, requiring no additional electrical work, batteries, or Internet connection for its seamless operation. Unlike IoT that require an Internet connection, this standalone voice recognition switches implemented the function of artificial intelligence voice recognition without any network. With this function, this switch can be used as a 1:1 direct replacement of a standard power on/ off switch, without additional electrical work or Internet connection. It is a stand-alone voice recognition switch made by receiving DC power from a single switch wire on the wall, combining it with an ultra-low power voice recognition sensor. The switch is also designed to be controlled by any standard infra-red remote controller, or by pressing the front panel button. This product is designed to be implemented in any languages in the world. The purpose of this product development is to make it easy and convenient for anyone to use a voice recognition switch, and it is designed as a product that can promote safety, especially for users with mobility difficulty.  It supports disabled Individuals and elderly person in: Independent Living: With voice recognition on/off switches integrated into home automation or assistive technology, disabled individuals can control various devices and perform tasks independently using voice commands. Reduced Physical Strain: Voice recognition eliminates the need for physically operating devices, making it easier for individuals with mobility challenges to interact with technology and appliances. A world’s first standalone voice recognition switch combines ultra-low power voice recognition sensors with its own power circuit, operates independently without Internet connectivity. It is designed to control the switch in 3 ways: Voice command within 5 meters, by pressing the front button and using a standard Infra-red remote controller. 1:1 direct replacement of a standard power on/ off switch No additional power line is needed Designed with overvoltage/ overcurrent protection circuits. This product is equipped with a distress rescue function and is also used by the Ministry of Health and Welfare of Korea as a safety system for the disabled and the socially disadvantaged. Smart wall switch, Electronics Related Equipment, Toys and electronic games, Consumer Products, Electric Companies Infocomm, Artificial Intelligence, Speech/Audio Analysis & Speech Recognition, Electronics, Power Management, Green Building, Lightings

Neural probes are used for capturing electrical activities and for exploring functional connectivity in the brain. For neural probes to be effective and be able to capture the activities happening at the scale of neural cells in vivo, they need to be small, made of bio-compatible material, and ideally, be flexible. This ensures that they do not trigger an inflammatory response or have a risk of breakage.  The technology presented here covers the requirements stated above for an ideal neural probe. The probes are flexible and allow superior precise targeting even with movement. The technology employed also avoids breaking and micromotion during the in-vivo trials. The probe’s design is also customizable for different requirements and can support combination of single/dual side, linear/tetrode, recording/stimulating/mixed and single/multi shank configurations for differing use cases. The probes can support up to 32 channels and provide multiple connectivity options for integration.  The probe has 8 to 32 nano-scale electrodes coated in biocompatible high-polymer materials. Its customizable channels can capture neural activities precisely and effectively in the electrochemical pool where neurons combine and communicate. Because of its nano-scale size, it can access the inner brain, such as the laboratory mouse’s hippocampus and motor cortex.   The  company also has expertise in making durable biomaterial circuit boards. The neural probe is built upon a flexible printed circuit board (fPCB), so the user does not have to worry about neural probe breaking inside the brain tissue. The following are some key technical features of the probe:  Probe physical size:  Length : 12mm + 5mm (Shank)  Width : 5.5mm to 20.5mm (Depends on number of channels)    Shank size:   Width : 153um  Thickness : 60um  Length : 5mm  Multiple shanks  Electrode size:  Diameter : 20 um   Distance between electrode: 50um  Type: Linear, Tetrode  Layer: Single side, Double, side  Channels & adaptors:  Channels : 8 to 32   Adaptors : Dip, Pin and Omnetics   The technology is suitable for applications in the field of medicine, bioengineering and neuroscience. The flexible probe can be used as a part of a more robust and precise measurement setup for monitoring and/or stimulating neural activity. The neural probe can safely be used in any current application requiring neural recording in in vivo or in vitro environment.  The technology offers a flexible neural probe which is customizable for use in different scenarios and experiments requiring neural monitoring and excitation. The main advantages of the technology can be summarized as:  Flexible – The neural probe is made of a polymer film and not the traditional brittle silicon material. This is accomplished using advanced fPCB engineering. This also allows safe neural recording for in vivo and in vitro experiments.  Configurable – The solution, in its current form, provides an easy way to connect the neural probe into any existing neural recording interface. The company provides various types of connectors and an option to customize these based on end- user’s request.   Economics – Aside from the different connectivity options, multiple existing configurations are available which help end user avoid the use of devices like a tetrode twister. This reduces the initial expenses for labs and companies trying out new configurations.  Adaptable – The probe can be used in diverse scenarios spanning deep brain stimulation to hippocampal neural recording.   Customizable – The probe design supports configurations involving multiple shanks and channels.  Biocompatibility – The probe is biocompatible and suitable for in vivo experiments.   Accuracy – The probe can detect neural spikes more accurately, collect cell clusters and track them reliably. The design also ensures that the neurons in contact around the probe’s micro scale shank can survive and act normally.  Medicine, Human Health, Diagnostics, Medical Technology, Biomendical, Neurology, Brain Research Electronics, Sensors & Instrumentation, Healthcare, Diagnostics, Medical Devices

With a projected market size of close to US$300M in 2025, printed thin film batteries are emerging as ideal candidates to power the next-generation wearables, medical and electronic devices. Unlike conventional batteries, printed thin-film batteries offers form-factor freedom, flexibility, providing power at sub-milimeter thickness and potentially cost effective to manufacture. Typically, zinc-manganese has been the chemistry of choice for printed batteries thanks to its low cost, high safety and ease of processing. Printed battery is manufactured by depositing conductive ink as a thin-film of paste onto a flexible polymer substrate (e.g., PET or heat-resistant polyimide films) by screen printing technique. Developed by an SME, the proprietary printed battery technology consists of layers of zinc anode, manganese dioxide cathode, electrolyte, separator, current collectors and sealing materials. The final battery is about 0.7 mm thick. While the energy capacities and size/shape could be customised depending on the use cases, the printed battery is best suited for applications at a power consumption of less than 50 mW. The technology owner may provide an initial assessment of the feasibility in using printed battery as a power source. If feasible, the technology owner may support in further brainstorming to optimise the power requirement and battery capacity for potential use cases. With a full grasp of the technical requirements, co-development activities including prototyping, battery integration with the final product (where applicable) will follow. For selected final products, the technology owner may serve as the original equipment manufacturer or original design manufacturer for the technology seeker. The standard non-rechargeable printed battery developed by the technology owner has the following technical specifications: Nominal voltage: 1.5 V to 3.0 V Initial capacities: 15 mAh @ 1 mA to 60 mAh @ 1 mA Initial internal resistance: ~20 Ω to ~90 Ω Maximum peak current: 25 mA for 5 ms Shelf life: minimum 2 years The outer dimensions, thickness and shape of battery as well as terminal size and location can be tailored according to the use cases: Customisation (area): 2 to 100 cm2 Customisation (capacity): up to 400 mAh Bending radius: the printed battery can be attached to a curved surface with a minimum radius of 35 mm. The thin film paper battery may be designed and customised to supply power to the following products and applications: Wireless sensor labels for temperature monitoring or asset tracking Wireless skin patches for monitoring vital signs Cosmetics patches and masks for skin care Smart wound healing dressings Intelligent packaging lighting, display and tracking New products that benefit from the thin and flexible form factor US$296M in 2025 and CAGR 24.7% from 2020-2025 (MarketsandMarkets, 2020) Customisable, flexible printed batteries for multiple applications. Printed battery, Flexible battery, Flexible electronics Energy, Battery & SuperCapacitor

Traditional methods of culturing organoids are labor-intensive, time-consuming, and limited in their ability to produce large quantities of organoids with consistent quality and characteristics. This technology enables the production of homogenized organoids of consistent quality. It utilizes specialized conditions to facilitate mass production and automate the cultivation of organoids derived from various tissues and organs, including the liver, kidney, lung, and brain. The IP addresses a need in the marketplace by providing a more efficient and cost-effective method of producing organoids. This technology reduces the time and cost of producing organoids while improving the reproducibility and scalability of the process. This can accelerate drug discovery and development, improve the accuracy of toxicology testing, enable the development of personalized medicine, and eventually replace the need for animal testing in the long-term vision of drug development. The technology provider will be producing the desired organoids as the end product with a further aim to enable a platform service for toxicity and efficacy testing when fully commercialized. The identity of the organoids will be validated by expression of relevant biomarkers. The end users of this technology are likely to be pharmaceutical companies, biotech firms, academic research institutions, and clinical laboratories. Overall, the technology has the potential to transform the way organoids are produced and used in the biomedical field. The technology owner is actively seeking for R&D collaboration to allow integration into existing protocols and testing with institutions, biotech companies and Contract Research Organizations (CROs). A bioink composition for organoids generation and characterisation Method for creating consistent cell droplets, culturing them in suspension, and sorting them by desired characteristics Cost-effective, leading to a 10x reduction in price Cryopreservation of organoids can be implemented for long-term storage and to ensure stable delivery This solution is intended to be a platform technology to be deployed in the biomedical industry, specifically in drug discovery on molecular drugs or gene therapies, toxicology testing, disease modeling, and personalized medicine, as well as CROs providing testing services and biotech firms developing early-stage drugs. The products that can be marketed based on this technology are organoid assays derived from various human tissues and organs, such as liver, kidney, lung, and brain. These organoids can be used for various applications, including: Testing drug toxicity and efficacy Investigating disease mechanisms and identifying drug targets Developing personalized therapies for patients The organoids market is projected to grow at a significant rate in the coming years, with an increasing demand for personalized medicine and improved drug discovery and toxicology testing methods. According to a report by MarketsandMarkets, the organoids market is expected to reach USD 1,642 million by 2025, growing at a CAGR of 20.4% from 2020 to 2025. The drug discovery outsourcing market was valued at USD 4.03 billion in 2020 and is also expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2021 to 2028, according to a report by Grand View Research. The increasing demand for novel and effective drugs, the rising cost of in-house drug development, and the need to expedite drug development timelines are some of the key factors driving the growth of this market. Pharmaceutical and biotech companies, as well as academic research institutions, are among the key buyers of drug discovery outsourcing services. These companies outsource drug discovery services to Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) to reduce costs and accelerate drug development timelines. The technology represents a significant improvement over the current state-of-the-art in organoid production. Currently, the most common methods for organoid production involve manual culturing, which is prone to variability and can be time-consuming and labor-intensive. Although some automation, such as the use of microfluidics and robotics, has been incorporated into organoid production, these methods are still limited in terms of organoid yield and quality. Our technology offers several advantages and differentiates itself from competitors in several ways: Scalability: One of the key advantages of this technology is its ability to scale up organoid production to an industrial level. The homogenization and suspension of organoids allow for efficient automation and mass production of organoids, reducing the time and cost of production. Standardization: The technology offers a more standardized and reproducible process for organoid production, reducing variability between batches and improving the accuracy of drug testing and development. Versatility: The technology can be applied to generate organoids from various organs and tissues, allowing researchers to study multiple disease models in a more comprehensive manner. This versatility allows for a wider range of applications and increases the potential market size. Cost-effectiveness: The streamlined process and scalability of the technology can lead to significant cost savings compared to other organoid production methods, making it more accessible to researchers and companies. Homogenized organoids, mass production, automation, drug discovery, toxicology testing, personalized medicine, reproducibility, scalability, transformative technology Healthcare, Pharmaceuticals & Therapeutics, Manufacturing, Additive Manufacturing, Life Sciences, Industrial Biotech Methods & Processes

Fermentation is an old method used mainly for food preservation. However, when the technology is well known and controlled, it can be a great asset for:1. Taste: improving the taste of foods and drinks or providing exotic flavors (umami)2. Texture: Improving the structure of foods and drinks by making them smoother, more tender or creamier, or in gluten-free baked products, making them crispier, chewier or with improved raising doughs.3. Nutrition value: improving the bioavailability of vitamins and minerals or other health promoting compounds.4. Health: when foods and drinks are fermented with probiotic bacteria, they can improve gut healthy and consumers lifestyleAny food company interested in having a premium quality in their product portfolio, should partner with us to developed better foods.We own the bacteria used for improving foods and drinks as well as the knowledge of how to use them in product development. The technology is based on more than 20 years of experience of isolating, studying and using microbes for the development of fermented plant-based ingredients which improve the taste, texture, nutrition value or healthiness of the food products using them.Our fermentation technology uses:- All kind of lactic acid bacteria- All kind of yeasts- All kind of moulds Our fermentation technology can be used for any plant-based ingredient. These fermented ingredients can then be used:1. Probiotic flavored waters, juices, smoothies, yogurts, cheeses, porridges (for gut health, better digestibility and nutritional value)2. Fermented cold coffees and teas (for gut health and nutritional value)3. Fermented green bean coffee for roasting (exotic taste and lower acrylamide)4. Fermented grains, pulses and all kind of flours (better digestibility, texture and nutritional value)5. Koji and miso from alternative sources (umami taste)  Global market size from the most relevant markets where fermentation technology can be used:Fermented                889 B USD (2023)  - CAGR 5%Healthy                     812 B USD (2021) - CAGR 6%Natural (Clean)         192 B USD (2023) - CAGR 13.7%Probiotics                   69 B USD (2023) - CAGR 7.0%Digestive health          58 B USD (2025) – CAGR 7.3%Healthy snacks           33 B USD (2025) - CAGR 5.1%Plant-based                 6.5 B USD (2028) - CAGR 7.1%Gluten-free                 4.9 B USD (2021) - CAGR 7.7% Food industry is looking for alternatives ways to have premium attributes that will make them stand out from the rest of competitors. Fermentation is starting to be very well known by the final consumer for improving their gut health and general wellbeing. Because of these, fermentation technology offers what food industry is looking for and we can help them use this technology and create premium food products for them. fermentation Foods, Ingredients, Quality & Safety, Processes